Literature DB >> 65644

Clozapine and agranulocytosis.

H J Senn, W F Jungi, H Kunz, W Pöldinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 65644     DOI： 10.1016/s0140-6736(77)91410-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The presynaptic component of the serotonergic system is required for clozapine's efficacy.

Authors:  Prem N Yadav; Atheir I Abbas; Martilias S Farrell; Vincent Setola; Noah Sciaky; Xi-Ping Huang; Wesley K Kroeze; LaTasha K Crawford; David A Piel; Michael J Keiser; John J Irwin; Brian K Shoichet; Evan S Deneris; Jay Gingrich; Sheryl G Beck; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

Review 2.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

Review 3.  On the possible mechanisms and predictability of clozapine-induced agranulocytosis.

Authors:  A V Pisciotta; S A Konings; L L Ciesemier; C E Cronkite; J A Lieberman
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

4.  Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study.

Authors:  Lun Yang; Kejian Wang; Jian Chen; Anil G Jegga; Heng Luo; Leming Shi; Chunling Wan; Xizhi Guo; Shengying Qin; Guang He; Guoyin Feng; Lin He
Journal:  PLoS Comput Biol       Date:  2011-03-31       Impact factor: 4.475

5.  The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice.

Authors:  Meghan May; Megan Beauchemin; Calvin Vary; Deborah Barlow; Karen L Houseknecht
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.